Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Itraconazole in fungal-sensitised severe asthma without ABPA
2004-002440-96Phase 4Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Jun 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in asthma and fungal sensitization comparing Itraconazole with Placebo (2 arms). Primary endpoint: Respiratory Quality of Life score (total) as per Juniper. Started Jun 2005; status: completed.
02
Drugs
itraconazole
03
Conditions
asthmafungal sensitization
Beyond the preview
Go deeper on 2004-002440-96.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002440-96.